Author Archives: Scalper1

Heron Therapeutics Soars On Pain Drug Success

Heron Therapeutics (HRTX) stock soared Wednesday after the biotech company reported success late Tuesday in a midstage trial of its drug for post-operative pain. Heron’s phase two study treated 64 patients who’d undergone a bunion removal. Those who took a 400 mg dose of Heron’s candidate HTX-011 showed a 69% reduction in pain intensity in the first 24 hours compared with the placebo group, and a 40% reduction after 72 hours. Patients on the drug

Verizon Leading U.S. Charge To IPv6 Connections

The U.S. is in the forefront of the global shift to Internet addresses using IPv6, the most recent version of the IP communication standard, says Akamai Technologies (AKAM) in its Q2 State of the Internet report. Cambridge, Mass.-based Akamai is the biggest provider of CDN, or content delivery network, services to media and entertainment companies, mainly providing video streaming. Its technology also speeds up e-commerce transactions and business